Thư viện tập trung - Thư viện điện tử

Sách, tuyển tập

SEA/RC60/12 - Progress reports requested by member states: avian and pandemic influenza preparedness in the context of the international health regulations (2005) / World Health Organization. Regional Office for South-East Asia

Tác giả : World Health Organization. Regional Office for South-East Asia

Nhà xuất bản : WHO Regional Office for South East-Asia

Năm xuất bản : 2007

Chủ đề : 1. Governing body documents.

Chia sẻ

Thông tin chi tiết

Tóm tắt :

Since November 2003, there have been 315 reported cases of human H5N1 infections with 191 deaths. In the South-East Asia Region, Thailand has had 25 reported cases with 17 deaths and Indonesia 101 human cases with 80 deaths. The H5N1 virus may be considered a pre-pandemic virus that could infect at least one billion people worldwide. Efforts to develop multisectoral pandemic preparedness plans and mobilize political and financial support in the Region are under way. Following-up on the Delhi Declaration on Avian Influenza Prevention and Control, WHO has assisted Member countries in developing National Influenza Pandemic Preparedness Plans (NIPPP), strengthening surveillance capacities in countries, building needed laboratories and developing technical guidelines for response, diagnosis and clinical management. It should be noted that this work also builds capacity for implementation of the International Health Regulations (IHR 2005). Several countries have received donor funding to support these efforts; another donor meeting, to be hosted by India will be held in December 2007. A recent issue involves production and availability of H5N1 and pandemic vaccines. Countries in the Region are concerned that they will not have access to commercially produced vaccines even though the virus used to develop these vaccines is from countries in the Region. WHO is assisting Member countries in the Region by helping to accredit at least two laboratories in the Region to identify the H5 virus. At the same time, WHO is coordinating international partnerships to support the production of pandemic vaccines in three countries of the Region. This is complemented by efforts to ensure an equitable and fair distribution of these vaccines, as needed by Member countries in the Region. This paper was submitted to the Joint Meeting of Heath Secretaries and the Consultative Committee for Programme Development and Management, held in the Regional Office from 2-6 July 2007 for its review. The Joint Meeting made the following recommendations: Action by Member States (1) To strengthen veterinary public health as part of an integrated multi-sectoral pandemic preparedness plan. The human health sector should take an active role to prevent infection from poultry to human beings, and minimise case fatality. (2) To apply non-pharmaceutical interventions such as risk communication and social distancing in addition to the use of vaccines and antiviral drugs during human pandemic phase. (3) To develop guidelines on the major components of NIPPP and conduct training in order to build up capacity in the implementation of NIPPP. (4) To develop/strengthen the core capacities as required by International Health Regulations (IHR) 2005 and the implementation of NIPPP, to cover capacities in both public and private sectors. (5) To foster public and private partnership in a concerted effort in the implementation of NIPPP, including resource mobilization. Action by WHO-SEARO (1) To continue to support Member States in the Region in the implementation of NIPPP, capacity building and strengthening of the National Regulatory Authority (NRA) to ensure that influenza vaccination is part of the NIPPP. (2) To operate the CSR unit in the Regional Office and two CSR sub-units in Delhi and Bangkok, including resource mobilization and stockpiling of antiviral, personal protection devices and pre-pandemic vaccines if available in future. (3) To report the progress on the implementation of Avian and Pandemic Influenza preparedness in the context of IHR 2005 to the Sixty-first, Sixty-second, Sixtythird, Sixty-fourth and Sixty-fifth sessions of the Regional Committee. The paper is now submitted to the Sixtieth session of the Regional Committee for its consideration.

Chia sẻ

Hiển thị MARC

Thông tin dữ liệu nguồn

Thư viện	Ký hiệu xếp giá	Dữ liệu nguồn
Tổ chức y tế thế giới		https://iris.who.int/handle/10665/128621

Ldr		00025nam a2200024 a 4500
001		CLN240988843
041	__	$aen
100	__	$aWorld Health Organization. Regional Office for South-East Asia
245	__	$aSEA/RC60/12 - Progress reports requested by member states: avian and pandemic influenza preparedness in the context of the international health regulations (2005) /$cWorld Health Organization. Regional Office for South-East Asia
260	__	$bWHO Regional Office for South East-Asia ,$c2007
500	__	$aSEA/HLP-Meet/8
520	__	$aSince November 2003, there have been 315 reported cases of human H5N1 infections with 191 deaths. In the South-East Asia Region, Thailand has had 25 reported cases with 17 deaths and Indonesia 101 human cases with 80 deaths. The H5N1 virus may be considered a pre-pandemic virus that could infect at least one billion people worldwide. Efforts to develop multisectoral pandemic preparedness plans and mobilize political and financial support in the Region are under way. Following-up on the Delhi Declaration on Avian Influenza Prevention and Control, WHO has assisted Member countries in developing National Influenza Pandemic Preparedness Plans (NIPPP), strengthening surveillance capacities in countries, building needed laboratories and developing technical guidelines for response, diagnosis and clinical management. It should be noted that this work also builds capacity for implementation of the International Health Regulations (IHR 2005). Several countries have received donor funding to support these efforts; another donor meeting, to be hosted by India will be held in December 2007. A recent issue involves production and availability of H5N1 and pandemic vaccines. Countries in the Region are concerned that they will not have access to commercially produced vaccines even though the virus used to develop these vaccines is from countries in the Region. WHO is assisting Member countries in the Region by helping to accredit at least two laboratories in the Region to identify the H5 virus. At the same time, WHO is coordinating international partnerships to support the production of pandemic vaccines in three countries of the Region. This is complemented by efforts to ensure an equitable and fair distribution of these vaccines, as needed by Member countries in the Region. This paper was submitted to the Joint Meeting of Heath Secretaries and the Consultative Committee for Programme Development and Management, held in the Regional Office from 2-6 July 2007 for its review. The Joint Meeting made the following recommendations: Action by Member States (1) To strengthen veterinary public health as part of an integrated multi-sectoral pandemic preparedness plan. The human health sector should take an active role to prevent infection from poultry to human beings, and minimise case fatality. (2) To apply non-pharmaceutical interventions such as risk communication and social distancing in addition to the use of vaccines and antiviral drugs during human pandemic phase. (3) To develop guidelines on the major components of NIPPP and conduct training in order to build up capacity in the implementation of NIPPP. (4) To develop/strengthen the core capacities as required by International Health Regulations (IHR) 2005 and the implementation of NIPPP, to cover capacities in both public and private sectors. (5) To foster public and private partnership in a concerted effort in the implementation of NIPPP, including resource mobilization. Action by WHO-SEARO (1) To continue to support Member States in the Region in the implementation of NIPPP, capacity building and strengthening of the National Regulatory Authority (NRA) to ensure that influenza vaccination is part of the NIPPP. (2) To operate the CSR unit in the Regional Office and two CSR sub-units in Delhi and Bangkok, including resource mobilization and stockpiling of antiviral, personal protection devices and pre-pandemic vaccines if available in future. (3) To report the progress on the implementation of Avian and Pandemic Influenza preparedness in the context of IHR 2005 to the Sixty-first, Sixty-second, Sixtythird, Sixty-fourth and Sixty-fifth sessions of the Regional Committee. The paper is now submitted to the Sixtieth session of the Regional Committee for its consideration.
655	__	$aGoverning body documents
856	__	$uhttps://iris.who.int/handle/10665/128621
900		1
907		https://iris.who.int/bitstream/handle/10665/128621/SEA_RC60_12%20done.pdf.jpg?sequence=4&isAllowed=y
925		G
926		0
927		SH

SEA/RC60/12 - Progress reports requested by member states: avian and pandemic influenza preparedness in the context of the international health regulations (2005) / World Health Organization. Regional Office for South-East Asia

Thông tin dữ liệu nguồn

Tài liệu cùng tác giả

Myanmar epilepsy initiative: piloting the WHO programme on reducing the epilepsy treatment gap 2013-2017 / World Health Organization. Regional Office for South-East Asia

2018 Health SDG Profile: Timor-Leste / World Health Organization. Regional Office for South-East Asia

2018 Health SDG Profile: Thailand / World Health Organization. Regional Office for South-East Asia

2018 Health SDG Profile: Sri Lanka / World Health Organization. Regional Office for South-East Asia

2018 Health SDG Profile: Nepal / World Health Organization. Regional Office for South-East Asia

Lời ngỏ

Mục đích và phương châm hoạt động

Bản quyền